scholarly journals P4-016: MCLENA-1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE

2019 ◽  
Vol 15 ◽  
pp. P1279-P1279
Author(s):  
Boris Decourt ◽  
Nadia Fulkerson ◽  
Alana Burns ◽  
Garam Lee ◽  
Tessa St Rose ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Phase Ii ◽  
Trial Design ◽  
Phase Ii Clinical Trial

P2-027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2-NGF GENE THERAPY FOR ALZHEIMER'S DISEASE

2006 ◽  
Vol 14 (7S_Part_12) ◽  
pp. P677-P677
Author(s):  
Michael J. Castle ◽  
Fernando Calvo Baltanas ◽  
Imre Kovacs ◽  
Alan H. Nagahara ◽  
Krystof S. Bankiewicz ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Gene Therapy ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Target Engagement ◽  
Ngf Gene

P3-037: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE

2006 ◽  
Vol 14 (7S_Part_20) ◽  
pp. P1078-P1079
Author(s):  
Kent L. Leslie ◽  
Joshua Cohen ◽  
Justin Klee ◽  
Victoria Williams ◽  
Steven E. Arnold
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Controlled Trial ◽  
Clinical Trial Design

P1-050: ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY-OF-ONSET PHASE 3 CLINICAL TRIAL

2006 ◽  
Vol 14 (7S_Part_5) ◽  
pp. P286-P286
Author(s):  
Carl Chiang ◽  
Robert Alexander ◽  
Kathleen A. Welsh-Bohmer ◽  
Brenda L. Plassman ◽  
Heather Romero ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Phase 3 ◽  
Endpoint Event ◽  
Onset Phase

scholarly journals P4-023: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE

2019 ◽  
Vol 15 ◽  
pp. P1282-P1283
Author(s):  
Kent L. Leslie ◽  
Justin Klee ◽  
Joshua Cohen ◽  
Victoria J. Williams ◽  
Suzanne B. Hendrix ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Phase Ii ◽  
Trial Design ◽  
Controlled Trial ◽  
Clinical Trial Design

P4-269: A pharmacogenetic-supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD)

2012 ◽  
Vol 8 (4S_Part_20) ◽  
pp. S753-S753 ◽  
Author(s):  
Allen D. Roses ◽  
Kathleen Welsh-Bohmer ◽  
Daniel Burns ◽  
Carl Chiang ◽  
Donna G. Crenshaw ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment
Sign in / Sign up

Export Citation Format

Share Document